NCT00080457View on ClinicalTrials.gov

Safety and Efficacy Study of Sitaxentan Sodium (Thelin™) in Patients With Pulmonary Arterial Hypertension

PHASE3CompletedINTERVENTIONAL
Enrollment

240

Participants

Timeline

Start Date

May 31, 2003

Study Completion Date

January 31, 2005

Conditions
Pulmonary Hypertension
Interventions
DRUG

sitaxsentan sodium

Trial Locations (1)

77401

Encysive Pharmaceuticals, Houston

Sponsors
All Listed Sponsors
lead

Encysive Pharmaceuticals

INDUSTRY

NCT00080457 - Safety and Efficacy Study of Sitaxentan Sodium (Thelin™) in Patients With Pulmonary Arterial Hypertension | Biotech Hunter | Biotech Hunter